ACM
QNCX icon

ADAR1 Capital Management’s Quince Therapeutics QNCX Stock Holding History

ADAR1 Capital Management’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.08K Buy
251
+36
+17% +$7.23K ﹤0.01% 308
2025
Q4 		$144K Sell
215
-3,660
-94% -$1.84M 0.01% 237
2025
Q3 		$1.26M Buy
3,875
+3,160
+442% +$1.05M 0.12% 96
2025
Q2 		$236K Hold
715
– – 0.04% 151
2025
Q1 		$190K Hold
715
– – 0.04% 148
2024
Q4 		$267K Hold
715
– – 0.05% 144
2024
Q3 		$111K Buy
715
+250
+54% +$35.8K 0.02% 184
2024
Q2 		$69.7K Buy
465
+331
+247% +$59.8K 0.01% 183
2024
Q1 		$28.4K Buy
+134
New +$33.3K 0.01% 208

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return